Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001209191-13-055952)

Filing Details

Accession Number:: 0001209191-13-055952
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2013-12-09 17:46:43
Reporting Period:: 2013-12-06

Filing Date:: 2013-12-09
Accepted Time:: 2013-12-09 17:46:43
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1516479	Insys Therapeutics Inc.	INSY	Pharmaceutical Preparations (2834)	510327886

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1033150	N John Kapoor	444 South Ellis Street Chandler AZ 85224		Yes	No	Yes	No
1575551	1989 20 September Dated Trust Kapoor N John	C/O Insys Therapeutics, Inc. 444 South Ellis Street Chandler AZ 85224		No	No	Yes	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2013-12-06	1,262	$47.24	0	No	4	S	Direct
Common Stock	Disposition	2013-12-06	18,713	$47.24	14,090,847	No	4	S	Indirect	By Trust
Common Stock	Disposition	2013-12-09	7,453	$47.26	14,083,394	No	4	S	Indirect	By Trust

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct
No	4	S	Indirect	By Trust
No	4	S	Indirect	By Trust

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	18,763	Indirect	By Partnership

Footnotes

Shares were sold for tax purposes; such shares were acquired prior to the acquisition by the Issuer (formerly NeoPharm, Inc.) of Insys Pharma, Inc. (former Insys Therapeutics, Inc.).
By The John N. Kapoor Trust dated September 20, 1989.
By EJ Financial/NEO Management, L.P., of which the Reporting Person is Managing General Partner.